HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Biosynthesis inhibitors for leukotrienes in bronchial asthma.

Abstract
This article reviews the literature on the effects of leukotrienes in asthma. In particular, the ability of recently developed synthesis inhibitors to attenuate the asthma causing effects of leukotrienes is examined. MEDLINE (1966-1996), EMBASE (Excerpta Medica; 1974-1996), and other biomedical and drug directory databases were searched to identify English-language articles (basic science, clinical trial research, and review articles) and abstracts of conference proceedings on biosynthesis inhibitors for leukotrienes and related terms. Leukotrienes are endogenous molecules formed by the breakdown of a membrane constituent, arachidonic acid, via the 5-Lipoxygenase enzyme pathway. This pathway ultimately produces several species of leukotrienes with various biologic activities, including generalized inflammatory effects associated with asthma: increased vascular permeability, enhanced mucous production, and decreased mucociliary transport. The biosynthesis inhibitors for leukotrienes attenuated the response to inhaled leukotrienes and allergen challenges (MK-0591; MK-886; AA-681; A-64077; ZD-2138). These agents produced beneficial effects in cold, exercise (A-64077) and aspirin-induced asthma (A-64077; ZD-2138), as well as clinical asthma. Many of these medications appear to be effective in the treatment of asthma (BAYX-1005; MK-0591; MK-886; AA-681; A-64077; ZD-2138; U-60257; FR-110302; BI-6239; A-78773; ABT-761; L-746530; L-699333; ZM-230487). Further clinical research is needed to determine which patients would benefit most from their use.
AuthorsJ M Negro, J C Miralles, J L Ortiz, E Funes, A García
JournalAllergologia et immunopathologia (Allergol Immunopathol (Madr)) 1997 Jul-Aug Vol. 25 Issue 4 Pg. 209-16 ISSN: 0301-0546 [Print] SPAIN
PMID9269512 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Asthmatic Agents
  • Benzoquinones
  • Indoles
  • Leukotrienes
  • Lipoxygenase Inhibitors
  • Naphthols
  • Pyrans
  • Quinolines
  • Quinolones
  • L 663536
  • FR 110302
  • 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid
  • zileuton
  • MK 0591
  • ICI D2138
  • 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone
  • Epoprostenol
  • piriprost
  • Hydroxyurea
Topics
  • Anti-Asthmatic Agents (pharmacology, therapeutic use)
  • Asthma (drug therapy)
  • Benzoquinones (pharmacology, therapeutic use)
  • Depression, Chemical
  • Epoprostenol (analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Hydroxyurea (analogs & derivatives, pharmacology, therapeutic use)
  • Indoles (pharmacology, therapeutic use)
  • Leukotrienes (biosynthesis)
  • Lipoxygenase Inhibitors (pharmacology, therapeutic use)
  • Naphthols (pharmacology, therapeutic use)
  • Pyrans (pharmacology, therapeutic use)
  • Quinolines (pharmacology, therapeutic use)
  • Quinolones (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: